Ammar Ron, Paton Tara A, Torti Dax, Shlien Adam, Bader Gary D
The Donnelly Centre, University of Toronto, Toronto, ON, M5S3E1, Canada.
The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, M5G0A4, Canada.
F1000Res. 2015 Jan 21;4:17. doi: 10.12688/f1000research.6037.2. eCollection 2015.
Haplotypes are often critical for the interpretation of genetic laboratory observations into medically actionable findings. Current massively parallel DNA sequencing technologies produce short sequence reads that are often unable to resolve haplotype information. Phasing short read data typically requires supplemental statistical phasing based on known haplotype structure in the population or parental genotypic data. Here we demonstrate that the MinION nanopore sequencer is capable of producing very long reads to resolve both variants and haplotypes of , and genes important in determining patient drug response in sample NA12878 of CEPH/UTAH pedigree 1463, without the need for statistical phasing. Long read data from a single 24-hour nanopore sequencing run was used to reconstruct haplotypes, which were confirmed by HapMap data and statistically phased Complete Genomics and Sequenom genotypes. Our results demonstrate that nanopore sequencing is an emerging standalone technology with potential utility in a clinical environment to aid in medical decision-making.
单倍型对于将基因实验室观察结果转化为具有医学可操作性的发现往往至关重要。当前的大规模平行DNA测序技术产生的短序列读段通常无法解析单倍型信息。对短读段数据进行定相通常需要基于群体中已知的单倍型结构或亲本基因型数据进行补充统计定相。在此我们证明,MinION纳米孔测序仪能够产生非常长的读段,以解析在CEPH/UTAH家系1463的样本NA12878中对确定患者药物反应很重要的 、 和 基因的变异和单倍型,而无需进行统计定相。来自单次24小时纳米孔测序运行的长读段数据被用于重建单倍型,这些单倍型由HapMap数据以及经统计定相的Complete Genomics和Sequenom基因型所证实。我们的结果表明,纳米孔测序是一种新兴的独立技术,在临床环境中具有潜在用途,有助于医疗决策。